A pharma miscellany.
October 1, 2009
The militant fringe of animal rights activists targets pharma.
 |
August 1, 2009
By:Peter Pitts
Dietary supplements function like drugs and are marketed like drugs. They should be regulated like ducks.
|
January 1, 2009
By:Stephen E. Gerard
How hopeful are execs about the future of their own companies and the industry in general?
|
November 1, 2008
HIV infection unzips its genes
|
October 1, 2008
By:Walter Armstrong
A head-to-head comparison of the Drug Vote '08
|
September 1, 2008
By:Walter Armstrong
Young & Partners crunches pharma's filings for, the first half of '08. The results? Ask the Japanese
|
August 1, 2008
By:Patrick Clinton
There's a cure for everything, as long as the patient is a mouse
|
July 1, 2008
By:Walter Armstrong
No, it's not as glamorous as its double-helixed offspring. But recent revelations about RNA turn even cold-eyed scientists into lyrical romantics
|
May 1, 2008
By:Walter Armstrong
A plunging currency and other economic turmoil shouldn't phase pharma, right? Yes and no
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?
Super Reps book trilogy by Dr. Lou Sawaya MD, MBA
Don't miss this Podcast series commemorating the 20th anniversary of HBA's Woman of the Year Award with interviews spanning two decades of change makers.
Conducting clinical trials in emerging regions can give you the edge. Five Quintiles experts share their insights into navigating the global regulatory landscape.